SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,712 | -25.4% | 24,701 | 0.0% | 0.00% | – |
Q2 2023 | $114,860 | +24.6% | 24,701 | +23.8% | 0.00% | – |
Q1 2023 | $92,206 | -42.8% | 19,958 | 0.0% | 0.00% | – |
Q4 2022 | $161,261 | +45.6% | 19,958 | 0.0% | 0.00% | – |
Q3 2022 | $110,767 | +24.5% | 19,958 | +16.6% | 0.00% | – |
Q2 2022 | $89,000 | -36.9% | 17,110 | 0.0% | 0.00% | – |
Q1 2022 | $141,000 | -44.7% | 17,110 | 0.0% | 0.00% | – |
Q4 2021 | $255,000 | -20.6% | 17,110 | +0.8% | 0.00% | -100.0% |
Q3 2021 | $321,000 | +1.6% | 16,982 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $316,000 | +1.9% | 16,982 | +24.7% | 0.00% | 0.0% |
Q1 2021 | $310,000 | +21.6% | 13,615 | +15.8% | 0.00% | 0.0% |
Q4 2020 | $255,000 | – | 11,760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
BVF INC/IL | 826,825 | $15,371,000 | 0.58% |